Tailored antibody-drug conjugate offers hope for aggressive breast cancer
Scientists have used breast cancer cells' weakness against themselves by linking a tumour-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
Stay updated with breaking news from Simon Vincent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scientists have used breast cancer cells' weakness against themselves by linking a tumour-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
Scientists have used breast cancer cells' weakness against themselves by linking a tumor-selective antibody with a cell-killing drug to destroy hard-to-treat tumors.
Researchers in Sheffield are investigating how breast cancer cells survive and grow, thanks to new funding from Breast Cancer Now.
The study also found that the most common place for new tumours to occur in these patients was in the womb, followed by the blood and the ovaries.
More deprived women were found to be at higher risk of lung, kidney, head and neck, bladder, oesophageal and stomach cancers